| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 81, 872-877, Copyright © 1996 by Endocrine Society
ARTICLES |
RN Margolis, E Canalis and NC Partridge
Endocrinology Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA. margolisr@cp.niddk.nth.gov
Age-, postmenopause-, and disease-related conditions that result in low bone mass represent important public health issues. Maintenance of bone mass is a balance between bone resorption and formation and is influenced by diet, body composition, activity level, and the interactions between and among a large number of hormones, growth factors, and cytokines. Recent research has emphasized establishing a more complete understanding of the hormonal regulation of bone and developing anabolic agents with therapeutic potential for the treatment of low bone mass. The NIDDK at the NIH recently sponsored a Workshop, entitled Anabolic Hormones in Bone: Basic Research and Therapeutic Potential, that attempted to define the current state of the art knowledge of hormones, growth factors, and cytokines that affect bone mass, with particular emphasis on those that could potentially have a role as anabolic agents in bone. This review presents a condensed proceedings of that workshop along with a summary of the optimal requisites for the development of anabolic agents with therapeutic potential in bone.
This article has been cited by other articles:
 |
|
 |
|
  D. C. Wan, J. H. Pomerantz, L. J. Brunet, J.-B. Kim, Y.-F. Chou, B. M. Wu, R. Harland, H. M. Blau, and M. T. Longaker Noggin Suppression Enhances in Vitro Osteogenesis and Accelerates in Vivo Bone Formation J. Biol. Chem., September 7, 2007; 282(36): 26450 - 26459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. MARGOLIS and S. J. WIMALAWANSA Novel Targets and Therapeutics for Bone Loss Ann. N.Y. Acad. Sci., April 1, 2006; 1068(1): 402 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Scarpa, D. De Brasi, R. Pivonello, P. Marzullo, F. Manguso, A. Sodano, P. Oriente, G. Lombardi, and A. Colao Acromegalic Axial Arthropathy: A Clinical Case-Control Study J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 598 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Devlin, Z. Du, R. C. Pereira, R. B. Kimble, A. N. Economides, V. Jorgetti, and E. Canalis Skeletal Overexpression of Noggin Results in Osteopenia and Reduced Bone Formation Endocrinology, May 1, 2003; 144(5): 1972 - 1978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Devlin, Z. Du, V. Buccilli, V. Jorgetti, and E. Canalis Transgenic Mice Overexpressing Insulin-Like Growth Factor Binding Protein-5 Display Transiently Decreased Osteoblastic Function and Osteopenia Endocrinology, October 1, 2002; 143(10): 3955 - 3962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Talbott, M. Cifuentes, M. G. Dunn, and S. A. Shapses Energy Restriction Reduces Bone Density and Biomechanical Properties in Aged Female Rats J. Nutr., September 1, 2001; 131(9): 2382 - 2387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bianda, Y. Glatz, R. Bouillon, E. R. Froesch, and C. Schmid Effects of Short-Term Insulin-Like Growth Factor-I (IGF-I) or Growth Hormone (GH) Treatment on Bone Metabolism and on Production of 1,25-Dihydroxycholecalciferol in GH-Deficient Adults J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 81 - 87. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
